SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 8,824.04 |
Enterprise Value ($M) | 17,224.04 |
Book Value ($M) | -1,250.00 |
Book Value / Share | -4.93 |
Price / Book | -7.06 |
NCAV ($M) | -8,128.00 |
NCAV / Share | -32.05 |
Price / NCAV | -1.09 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.16 |
Return on Assets (ROA) | 0.13 |
Return on Equity (ROE) | 0.28 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.20 |
Current Ratio | 1.61 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 3,719.00 |
Assets | 10,597.00 |
Liabilities | 11,847.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 6,304.00 |
Operating Income | 2,035.00 |
Net Income | 1,351.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 2,458.00 |
Cash from Investing | -481.00 |
Cash from Financing | -1,333.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 11.35 | -0.48 | |
13G | BlackRock Inc. | 6.70 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
85,907 | 654,084 | 13.13 | |
101,623 | 726,493 | 13.99 | |
151,828 | 1,053,082 | 14.42 | |
270,847 | 1,270,971 | 21.31 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Similar Companies | |
---|---|
NUVB – Nuvation Bio Inc | NVO – Novo-Nordisk A/S |
NVS – Novartis AG | PBH – Prestige Brands Holdings, Inc. |
PFE – Pfizer Inc. |
Financial data and stock pages provided by
Fintel.io